Carclo (Carclo) ROCE % : 0.99% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Carclo ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Carclo's annualized ROCE % for the quarter that ended in Sep. 2023 was 0.99%.

Carclo ROCE % Historical Data

The historical data trend for Carclo's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carclo ROCE % Chart

Carclo Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

2.03

3.09

13.52

9.29

1.45

Carclo Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROCE %	Get a 7-Day Free Trial															12.87	6.51	6.02	-3.99	0.99

Carclo ROCE % Calculation

Carclo's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	1.756	/	( ( (168.904 - 36.92)	+	(148.874 - 38.82) )	/ 2 )
	=	1.756	/	( (131.984	+	110.054)	/ 2 )
	=	1.756	/	121.019
	=	1.45 %

Carclo's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Mar. 2023 )		(Q: Sep. 2023 )
	=	1.04	/	( ( (148.874 - 38.82)	+	(137.896 - 38.285) )	/ 2 )
	=	1.04	/	( ( 110.054	+	99.611 )	/ 2 )
	=	1.04	/	104.8325
	=	0.99 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

Carclo (OTCPK:CCEGF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Carclo ROCE % Related Terms

Thank you for viewing the detailed overview of Carclo's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Carclo (Carclo) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Vehicles & Parts » Carclo PLC (OTCPK:CCEGF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CARl:UK CAR.GB:UK CAR:UK C1Y:Germany

Address

Unit 5, Silkwood Court, Ossett, W Yorks, GBR, WF5 9TP

Website

http://www.carclo-plc.com

Carclo PLC is a technology-led plastics group that is engaged in three segments: CTP, Aerospace, and Central. The CTP segment supplies value-adding engineered solutions for the life science, optical and precision component industries. This business operates internationally in a fast?growing and dynamic market underpinned by rapid technological development. The Aerospace segment supplies systems to the manufacturing and aerospace industries. The central segment relates to central costs and non-trading companies. Geographically, it operates in the regions of the UK, North America, China, and India. The company earns three-fifths of its revenue from medical products, and the balance of the revenue is generated from the automotive industry.